semaglutide and svt Cardiovascular outcomes of tirzepatide for patients with type 2 diabetes in clinical practice Retatrutide vs Tirzepatide vs Semaglutide:

It seems like everyone in Hollywood is buzzing about GLP-1 drugs

The TRIUMPH programme will investigate retatrutide in people with obesity and the TRANSCEND-T2D programme is investigating retatrutide in people with T2D and overweight/obesity

they are part of a structured, physician-directed approach that elevates how we think about body transformation

it is formulated for external cosmetic use only, focusing on aesthetic skin benefits and routine cleansing

CrossRef Efficacy and safety of anti-obesity drugs in metabolic dysfunction-associated steatotic liver disease: An updated review Marcio J Concepcin-Zavaleta, Jenyfer M Fuentes-Mendoza, Jhean G Gonzles-Yovera, Gemma Y Ruvalcaba-Barbosa, Leonardo D Cura-Rodrguez, Josu S Gonzlez-Rodrguez, Luis A Concepcin-Urteaga, Aranza I Prez-Reyes, Juan Eduardo Quiroz-Aldave, Jos Paz-Ibarr World Journal of Gastroenterology.2025;[Epub] CrossRef Paliurus ramosissimus Leaf Extract Inhibits Adipocyte Differentiation In Vitro and In Vivo High-Fat Diet-Induced Obesity Through PPAR Suppression Shin-Hye Kim, Tae Hyun Son, Hye-Lim Shin, Dongsoo Kim, Gwang Hun Park, Jeong Won Seo, Hwan-Gyu Kim, Sik-Won Choi Pharmaceuticals.2025